Aileen W.

Aileen W. is an experienced finance executive currently serving as the CFO of Fosun Pharma USA Inc. since October 2023. Previously, Aileen held the position of Chief Financial Officer at Clover Biopharmaceuticals, where responsibilities included transforming the organization from a clinical stage to a commercial stage and leading finance, procurement, and investor relations teams. Aileen's career also includes significant roles at Novartis Gene Therapies as Global Head of Central Business Planning & Analysis and various finance leadership positions within Novartis, focusing on financial management, forecasting, and P&L responsibility. Earlier roles include Global Corporate Audit Manager at Grainger and Finance/Internal Control Manager at Motorola Mobility, as well as foundational experience at Arthur Andersen & Co. Aileen holds an MBA in Finance from Penn State University and a Bachelor of Engineering degree from Shanghai Jiao Tong University.